Trademark Overview
On Wednesday, January 14, 2026, a trademark application was filed for LAZVUE with the United States Patent and Trademark Office. The USPTO has given the LAZVUE trademark a serial number of 99593960. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, May 12, 2026. This trademark is owned by Beacon Therapeutics Limited. The LAZVUE trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical treatment services; Provision of medical information and services; Information provided to patients and healthcare professionals concerning pharmaceutical products, preparations for gene therapy and cell therapy, medical diseases and disorders and related treatments; Medical treatment services in the field of ocular disorders; Provision of medical information and services in the field of ocular disorders.
Medical apparatus and instruments; medical apparatus and instruments used in the treatment of ocular disorders; apparatus and instruments for the administration of pharmaceutical preparations; apparatus and instruments for the injection of pharmaceutical preparations; medical apparatus and instruments for use in gene therapy and cell therapy.
Pharmaceutical preparations and substances; preparations for gene therapy and cell therapy; Pharmaceutical preparations and substances for the treatment of ocular disorders; biotechnological preparations for the treatment of ocular disorders; preparations for gene therapy and cell therapy for the treatment of ocular disorders; genetic medicines for the treatment of ocular disorders.